ARTICLE | Company News
Advion, Quintiles deal
October 31, 2011 7:00 AM UTC
Quintiles will acquire fellow CRO Advion for an undisclosed amount in cash. Advion provides pharmacokinetic/pharmacodynamic testing, molecular screening, drug discovery and metabolism, biomarker disco...